Virbac S.A.
VRBCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $738 | $694 | $703 | $636 |
| % Growth | 6.3% | -1.2% | 10.4% | – |
| Cost of Goods Sold | $241 | $240 | $220 | $226 |
| Gross Profit | $497 | $455 | $483 | $410 |
| % Margin | 67.4% | 65.5% | 68.7% | 64.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $332 | -$303 | $303 | $302 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $33 | $638 | $72 | $32 |
| Operating Expenses | $365 | $336 | $374 | $335 |
| Operating Income | $132 | $119 | $109 | $75 |
| % Margin | 17.9% | 17.1% | 15.4% | 11.9% |
| Other Income/Exp. Net | -$8 | -$53 | $34 | -$11 |
| Pre-Tax Income | $124 | $66 | $142 | $65 |
| Tax Expense | $42 | $15 | $47 | $18 |
| Net Income | $82 | $51 | $95 | $46 |
| % Margin | 11.2% | 7.3% | 13.5% | 7.3% |
| EPS | 9.84 | 6.06 | 11.29 | 5.54 |
| % Growth | 62.4% | -46.3% | 103.8% | – |
| EPS Diluted | 9.83 | 6.05 | 11.29 | 5.53 |
| Weighted Avg Shares Out | 8 | 8 | 8 | 8 |
| Weighted Avg Shares Out Dil | 8 | 8 | 8 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $6 | $0 | $9 |
| Interest Expense | $3 | $11 | $0 | $10 |
| Depreciation & Amortization | $24 | $38 | $20 | $18 |
| EBITDA | $157 | $108 | $169 | $96 |
| % Margin | 21.2% | 15.5% | 24% | 15.1% |